InvestorsObserver
×
News Home

Where Does Akero Therapeutics Inc (AKRO) Stock Fall in the Biotechnology Field?

Tuesday, December 22, 2020 03:30 PM | InvestorsObserver Analysts

Mentioned in this article

Where Does Akero Therapeutics Inc (AKRO) Stock Fall in the Biotechnology Field?

The 62 rating InvestorsObserver gives to Akero Therapeutics Inc (AKRO) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 76 percent of stocks in the Biotechnology industry, AKRO’s 62 overall rating means the stock scores better than 62 percent of all stocks.

Overall Score - 62
AKRO has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on AKRO!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Akero Therapeutics Inc Stock Today?

Akero Therapeutics Inc (AKRO) stock has gained 3.4% while the S&P 500 is lower by -0.22% as of 3:14 PM on Tuesday, Dec 22. AKRO has gained $0.87 from the previous closing price of $25.62 on volume of 255,146 shares. Over the past year the S&P 500 is higher by 14.35% while AKRO has gained 21.96%. AKRO lost -$2.16 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Akero Therapeutics Inc (AKRO) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App